Showing results (1791-1800 of 2,530) with videos related to

Sort By:
Pageof 253
Evolution; International Journal of Organic Evolution|January 10, 2023
Larval transcriptomes reflect the evolutionary history of plant-insect associationsMaria de la Paz Celorio-Mancera, Rachel A Steward, Peter Pruisscher, et al.
Drug and Alcohol Dependence|May 13, 2008
Randomized, placebo-controlled trial of bupropion for the treatment of methamphetamine dependenceSteven Shoptaw, Keith G Heinzerling, Erin Rotheram-Fuller, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 23, 2018
Utility and Generalizability of Multistate, Population-Based Cancer Registry Data for Rural Cancer Surveillance Research in the United StatesWhitney E Zahnd, Wiley D Jenkins, Aimee S James, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|March 20, 2001
Expression and immunolocalization of aquaporin water channels in rat exocrine pancreasP T Hurley, C J Ferguson, T H Kwon, et al.
Antimicrobial Agents and Chemotherapy|November 19, 2002
Carbapenem resistance in a clinical isolate of Enterobacter aerogenes is associated with decreased expression of OmpF and OmpC porin analogsHesna Yigit, Gregory J Anderson, James W Biddle, et al.
British Journal of Haematology|December 31, 1997
Same-day determination of chimaeric status in the immediate period following allogeneic bone marrow transplantationJ P Hancock, M F Burgess, N J Goulden, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 13, 2015
Identification of the inflammasome Nlrp1b as the candidate gene conferring diabetes risk at the Idd4.1 locus in the nonobese diabetic mouseVinicius N Motta, Janet G M Markle, Omid Gulban, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 16, 2007
A phase IB, open-label dose-escalating study of the oral angiogenesis inhibitor PTK787/ZK 222584 (PTK/ZK), in combination with FOLFOX4 chemotherapy in patients with advanced colorectal cancerA L Thomas, T Trarbach, C Bartel, et al.
Pageof 253